Lonza invests in exosome category, acquires development and manufacturing capabilities 04-Nov-2021 By Jane Byrne Lonza has been investing in developing exosome manufacturing and characterization technologies for the past five years, and this week it ramped up its focus on that category by acquiring two sites.
